With EUAs recently granted for updated bivalent COVID-19 vaccines for children under five, the COVID-19 Vaccine Education and Equity Project convened a virtual fireside chat with FDA and pediatric experts to discuss the rationale for updated shots and address questions around eligibility and effectiveness amid the holiday season.

Panelists included:

• Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research (CBER)
• Dr. Dana DeShon, DNP, APRN, CPNP-PC, Chair, NAPNAP Immunization Special Interest Group

Watch the event here: